Literature DB >> 18851982

Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?

E Tulupova1, R Kumar, M Hanova, J Slyskova, B Pardini, V Polakova, A Naccarati, L Vodickova, J Novotny, J Halamkova, K Hemminki, P Vodicka.   

Abstract

The Czech Republic presents one of the highest incidences of colorectal cancer in the world. We genotyped 10 single nucleotide polymorphisms in five DNA mismatch repair genes in 614 colorectal cancer cases and 614 matched controls from this country. The carriers of T-allele of the hMSH6-556G>T polymorphism were at increased risk of colorectal cancer (OR 1.29; 95% CI 1.02-1.62). The stratification of data showed that risk associated with the polymorphism was confined to rectal cancer (OR 1.42; 95% CI 1.03-1.95). The A-allele of the Ex1-145G>A polymorphism in the hMSH6 gene was associated with a decreased risk of colorectal cancer (OR 0.76; 95% CI 0.60-0.98). The C-allele of the IVS4-101G>C polymorphism in hMSH6 was associated with an increased risk of colon cancer (OR 1.34; 95% CI 1.03-1.74). The carriers of the variant allele for the polymorphism IVS9-1406C>T in hMLH1 exhibited a decreased risk of rectal cancer (OR 0.71; 95% CI 0.51-0.98). We observed a differential distribution of haplotypes based on three hMSH6 polymorphisms (-556G>T-Ex1-145G>A-IVS4-101G>C) in the cases and controls (global P=0.02). The TAG haplotype was associated with a decreased risk of colorectal cancer (OR 0.74; 95% CI 0.59-0.92), whereas the most frequent haplotype GGG was associated with increased risk of rectal cancer (OR 1.32; 95% CI 1.05-1.65). However, multiple hypotheses testing diminishes a statistical significance of above associations. Our data suggest a limited role for the investigated individual variants in mismatch repair genes for the susceptibility to the disease. The haplotypes covering hMSH6 gene may, however, be involved in risk modulation in this population.

Entities:  

Mesh:

Year:  2008        PMID: 18851982     DOI: 10.1016/j.mrfmmm.2008.09.005

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  12 in total

1.  Intronic and promoter polymorphisms of hMLH1/hMSH2 and colorectal cancer risk in Heilongjiang Province of China.

Authors:  Guangxiao Li; Fulan Hu; Fengshun Yuan; Jialong Fan; Zhifu Yu; Zhiwei Wu; Xiaojuan Zhao; Ye Li; Shuying Li; Jiesheng Rong; Binbin Cui; Xinshu Dong; Huiping Yuan; Yashuang Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-06       Impact factor: 4.553

2.  Association between the hMSH2 IVS12-6 T>C polymorphism and cancer risk: A meta-analysis.

Authors:  Song Wu; Jingyu Chen; Yong Ji; Yuxin Liu; Lu Gao; Guoqiang Chen; Kai Shen; Bin Huang
Journal:  Exp Ther Med       Date:  2011-08-16       Impact factor: 2.447

3.  Association between MSH6 G39E polymorphism and cancer susceptibility: a meta-analysis of 7,046 cases and 34,554 controls.

Authors:  Zuming Li; Lihua Kong; Ling Yu; Jiao Huang; Ke Wang; Shi Chen; Miao Yu; Sheng Wei
Journal:  Tumour Biol       Date:  2014-03-13

Review 4.  Hereditary and familial colon cancer.

Authors:  Kory W Jasperson; Thérèse M Tuohy; Deborah W Neklason; Randall W Burt
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

5.  Role of rare variants in undetermined multiple adenomatous polyposis and early-onset colorectal cancer.

Authors:  Jérémie H Lefevre; Carolina Bonilla; Chrystelle Colas; Bruce Winney; Elaine Johnstone; Susan Tonks; Tammy Day; Katarzyna Hutnik; Abdelhamid Boumertit; Florent Soubrier; Rachel Midgley; David Kerr; Yann Parc; Walter F Bodmer
Journal:  J Hum Genet       Date:  2012-08-09       Impact factor: 3.172

6.  Association between MutL homolog 1 polymorphisms and the risk of colorectal cancer: a meta-analysis.

Authors:  Haiyan Chen; Zhujing Shen; Yeting Hu; Qian Xiao; Dikai Bei; Xiangfeng Shen; Kefeng Ding
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-19       Impact factor: 4.553

7.  Mismatch repair single nucleotide polymorphisms and thyroid cancer susceptibility.

Authors:  Luís S Santos; Susana N Silva; Octávia M Gil; Teresa C Ferreira; Edward Limbert; José Rueff
Journal:  Oncol Lett       Date:  2018-02-21       Impact factor: 2.967

8.  The MLH1 2101C>A (Q701K) variant increases the risk of gastric cancer in Chinese males.

Authors:  Wenxian Zhi; Binshuang Xue; Lifeng Wang; Nong Xiao; Qiong He; Yaping Wang; Yimei Fan
Journal:  BMC Gastroenterol       Date:  2011-12-03       Impact factor: 3.067

9.  COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer.

Authors:  I P M Tomlinson; M Dunlop; H Campbell; B Zanke; S Gallinger; T Hudson; T Koessler; P D Pharoah; I Niittymäki; I Niittymäkix; S Tuupanen; S Tuupanenx; L A Aaltonen; K Hemminki; A Lindblom; A Försti; O Sieber; L Lipton; T van Wezel; H Morreau; J T Wijnen; P Devilee; K Matsuda; Y Nakamura; S Castellví-Bel; C Ruiz-Ponte; A Castells; A Carracedo; J W C Ho; P Sham; R M W Hofstra; P Vodicka; H Brenner; J Hampe; C Schafmayer; J Tepel; S Schreiber; H Völzke; M M Lerch; C A Schmidt; S Buch; V Moreno; C M Villanueva; P Peterlongo; P Radice; M M Echeverry; A Velez; L Carvajal-Carmona; R Scott; S Penegar; P Broderick; A Tenesa; R S Houlston
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

10.  Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.

Authors:  Ting Wang; Yang Liu; Li Sima; Liang Shi; Zhaoming Wang; Chunhui Ni; Zhengdong Zhang; Meilin Wang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.